NEOMAX F

Riik: Iirimaa

keel: inglise

Allikas: Ecolab

Saadav alates:

ECOLAB DEUTSCHLAND GMBH

Ohutuskaart

SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
NEOMAX F
115812E
1 / 11
SECTION: 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE
COMPANY/UNDERTAKING
1.1 PRODUCT IDENTIFIER
Product name
:
NEOMAX F
Product code
:
115812E
Use of the
Substance/Mixture
:
Cleaning product
Substance type:
:
Mixture
FOR PROFESSIONAL USERS ONLY.
Product dilution information
:
No dilution information provided.
1.2 RELEVANT IDENTIFIED USES OF THE SUBSTANCE OR MIXTURE AND USES
ADVISED AGAINST
Identified uses
:
Floor cleaner. Semi-Automatic process
Recommended restrictions
on use
:
Reserved for industrial and professional use.
1.3 DETAILS OF THE SUPPLIER OF THE SAFETY DATA SHEET
Company
:
Ecolab Ltd.
PO Box 11; Winnington Avenue
Northwich, Cheshire, United Kingdom CW8 4DX
[phone]
[e-mail]
1.4 EMERGENCY TELEPHONE NUMBER
Emergency telephone
number
:
[phone]
[phone] Trans-European
Poison Information Centre
telephone number
:
For medical professionals only:
[phone] (8am-10pm)
Date of Compilation/Revision
:
25.03.2019
Version
:
2.2
SECTION: 2. HAZARDS IDENTIFICATION
2.1 CLASSIFICATION OF THE SUBSTANCE OR MIXTURE
CLASSIFICATION (REGULATION (EC) NO 1272/2008)
Not a hazardous substance or mixture.
2.2 LABEL ELEMENTS
LABELLING (REGULATION (EC) NO 1272/2008)
Not a hazardous substance or mixture.
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
NEOMAX F
115812E
2 / 11
2.3 OTHER HAZARDS
None known.
SECTION: 3. COMPOSITION/INFORMATION ON INGREDIENTS
3.2 MIXTURES
Remarks
:
No hazardous ingredients
SECTION: 4. FIRST AID MEASURES
4.1 DESCRIPTION OF FIRST AID MEASURES
In case of eye contact
:
Rinse with plenty of water.
In case of skin contact
:
Rinse with plenty of water.
If swallowed
:
Rinse mouth. Get medical attention if symptoms occur.
If inhaled
:
Get medical attention if symptoms occur.
4.2 MOST IMPORTANT SYMPTOMS AND EFFECTS, BOTH ACUTE AND DELAYED
See Section 11 for more detailed information on health effects and
symptoms.
4.3 INDICATION OF IMMEDIATE MEDICAL ATTENTION AND SPEC